Skip to main content
    D

    Doximity Inc (DOCS)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NYSE

    $32.79
    -0.55 (-1.65%)

    Market Cap: $5.95B

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Doximity Inc (DOCS) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Doximity (DOCS) to earn $1.35 per share in the fiscal year ending Mar 31, 2027, on revenue of $680.26M. Of 21 analysts, 8 rate the stock Buy or Strong Buy, 11 Hold and 2 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Mar 31, 2027 was revised up and 1 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 21 ratings average 2.52, inside the Hold band from 2.5 up to 3.5. Buy and Strong Buy make up 38% of the ratings.

    RatingAnalystsShare
    Strong Buy523.8%
    Buy314.3%
    Hold1152.4%
    Sell14.8%
    Strong Sell14.8%
    Consensus
    Hold
    Total analysts
    21

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus rises 14.8% and revenue estimates rise 6.3%.

    Fiscal year ending Mar 31, 2027
    $1.35
    EPS consensus, revenue $680.26M
    Fiscal year ending Mar 31, 2028
    $1.55
    EPS consensus, revenue $722.83M
    Next report
    Feb 3, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Mar 31, 2027$1.35$1.27 to $1.4518$680.26M$673.30M to $683.20M20
    Mar 31, 2028$1.55$1.41 to $1.7516$722.83M$693.48M to $748.40M18

    Quarterly Estimates

    The EPS consensus falls from $0.44 for the quarter ending Dec 31, 2026 to $0.26 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$0.44$0.39 to $0.5117$195.53M$195.00M to $196.20M17
    Mar 31, 2027$0.26$0.22 to $0.3224$157.52M$147.15M to $171.99M21

    Estimate Revisions

    Across the 2 periods below, the last 30 days brought 13 upward and 2 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Mar 31, 202711
    Quarter ending Dec 31, 2026121

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has fallen 0.7% from $1.36.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Mar 31, 2027$1.35$1.35$1.35$1.35$1.36-1.2%
    Fiscal year ending Mar 31, 2028$1.55$1.56$1.56$1.55$1.56-0.5%
    Quarter ending Dec 31, 2026$0.44$0.42$0.42$0.42$0.42+5.8%

    Frequently Asked Questions About DOCS

    What is the DOCS stock forecast?

    Consensus analyst estimates put Doximity's EPS at $1.35 for the fiscal year ending Mar 31, 2027, on revenue of $680.26M. The consensus rating from 21 analysts is Hold.

    How do analysts rate DOCS stock?

    Of 21 analysts covering Doximity, 5 rate it Strong Buy, 3 Buy, 11 Hold, 1 Sell and 1 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from DOCS next year?

    For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $1.35, with estimates from $1.27 to $1.45 from 18 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $1.55, with estimates from $1.41 to $1.75 from 16 analysts.

    What revenue do analysts expect from Doximity next year?

    For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $680.26M, with estimates from $673.30M to $683.20M. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $722.83M, with estimates from $693.48M to $748.40M.

    How many analysts cover DOCS?

    21 analysts rate Doximity stock, and 18 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.